Search results
Pfizer’s reported net income declines 44% in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 2 days agoPfizer’s reported net income stood at $3.11bn in the first quarter (Q1) of 2024, marking a decrease of 44% from $5.54bn posted in Q1 2023. The...
Pfizer Stock Rises as Outlook Raised After Earnings Beat
Barrons.com· 3 days agoPfizer reports first-quarter adjusted earnings of 82 cents a share on revenue of $14.88 billion.Read...
Pfizer: Q1 Earnings Snapshot
Midland Reporter-Telegram· 3 days agoNEW YORK (AP) — NEW YORK (AP) — Pfizer Inc. (PFE) on Wednesday reported first-quarter...
Pfizer and Genmab’s Tivdak wins full FDA approval for cervical cancer
Pharmaceutical Technology via Yahoo Finance· 4 days agoPfizer and Genmab’s Tivdak (tisotumab vedotin-tftv) has won full approval from the US Food and Drug...
Vanguard Health Care Fund's Strategic Moves in Q1 2024: A Focus on Pfizer Inc
GuruFocus.com via Yahoo Finance· 21 hours agoReductions in Key Positions Conversely, the fund reduced its position in several stocks, including a...
Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid By Reuters
Investing.com· 3 days agoSales of Padcev, a treatment for advanced bladder cancer Pfizer (NYSE:PFE) gained through its $43...
Pfizer Stock Gets Boost From Better-Than-Expected Earnings
Investopedia· 3 days agoPfizer (PFE) shares rose Wednesday after first-quarter earnings and revenue fell less than expected,...
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
NBC Los Angeles· 3 days agoPfizer reported first-quarter revenue that beat expectations and hiked its full-year profit outlook,...
Analyst Report: Pfizer Inc.
Morningstar Research via Yahoo Finance· 2 days agoPfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types ...
Amazon, Pfizer, Pinterest rise premarket; AMD, Starbucks, CVS Health fall By Investing.com
Investing.com· 3 days agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks...